Design, Characterization and Evaluation of Transdermal Patches of Zaltoprofen
Abstract
The oral route of administering drugs has several drawbacks, such as limited bioavailabilitydue to to hepatic first-pass metabolism and a tendency to generate rapid, either high or low blood level spikes. In the current study, transdermal administration of Zaltoprofen was designed to circumvent first pass metabolism and reduce dose frequency compared to oral route. Matrix type transdermal patches were prepared using polymers such as Eudragit-L100, HPMCK 4M, and HPMCK 15M by employing solvent casting technique method. Propylene glycol and tween 80 were choosen as permeation enhancer and plasticizer respectively. F1 to F12 are designed at variable proportions of drug to polymer ratios. All the formulations were characterized. No drug-excipient interactions were found in FTIR studies. In invitro drug permeation studies, the F6 formulation exhibited 94.7% drug release over a period of 12-hours. Release kinetics of F6 has shown anomalous diffusion or non-fickian diffusion (swellable & cylindrical Matrix) and follows Peppa's method of drug release. Propylene glycol (PG) reduced skin irritation which is confirmed in skin irritation test. In stability studies the physical appearance and drug content of Zaltoprofen transdermal patch was found to be uniform.